3 Stocks I Saw on T...
Health Care: Drugs
Flamel Technologies (FLML: NASDAQ)
$4.43 0.09 | 1.98%
06/04/12 - 12:14 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 3.46M | 8.18M | 8.72M | 27.02M |
| Receivables | 7.84M | 9.78M | 18.08M | 18.09M |
| Inventories | 1.68M | 862.00K | 1.07M | 1.84M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 36.65M | 45.36M | 66.84M | 59.19M |
| Property, Plant & Equipment, Gross | 63.37M | 66.54M | 68.60M | 65.51M |
| Accumulated Depreciation & Depletion | 43.98M | 45.11M | 43.84M | 37.91M |
| Property, Plant & Equipment, Net | 19.38M | 21.42M | 24.76M | 27.60M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 13.37M | 7.83M | 2.70M | 5.07M |
| Total Non-Current Assets | 32.75M | 29.25M | 27.46M | 32.67M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 69.40M | 74.61M | 94.30M | 91.86M |
| Accounts Payable | 3.92M | 5.08M | 7.22M | 6.35M |
| Short Term Debt | 2.12M | 2.38M | 895.00K | 753.00K |
| Other Current Liabilities | 3.96M | 3.43M | 4.60M | 6.45M |
| Total Current Liabilities | 18.31M | 19.42M | 22.90M | 20.26M |
| Long Term Debt | 1.69M | 1.55M | 2.94M | 2.27M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 19.35M | 17.21M | 23.53M | 20.70M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 21.29M | 18.89M | 26.54M | 23.06M |
| Total Liabilities | 39.61M | 38.31M | 49.43M | 43.32M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 29.79M | 36.30M | 44.86M | 48.55M |
| Common Par | 3.64M | 3.59M | 3.54M | 3.52M |
| Additional Paid In Capital | 205.49M | 202.46M | 198.50M | 193.08M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -189.39M | -180.62M | -171.64M | -160.20M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 10.06M | 10.87M | 14.47M | 12.15M |
| Total Capitalization | 31.48M | 37.85M | 47.81M | 50.82M |
| Total Equity | 29.79M | 36.30M | 44.86M | 48.55M |
| Total Liabilities & Stock Equity | 69.40M | 74.61M | 94.30M | 91.86M |
| Total Common Shares Outstanding | 24.96M | 24.65M | 24.34M | 24.20M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 24.67M | 24.41M | 24.22M | 24.08M |
| Diluted Weighted Shares Outstanding | 24.67M | 24.41M | 24.22M | 24.08M |
| Number of Employees | 267 | 291 | 302 | 284 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with FLML
- Portfolio NameUser Type
- Contributor10 Top-Rated Buys Under $10
- Contributor10 Stocks Under $10 With Up...
- Usergreentree
- UserSalvelinus Fontinalis
- UserBVF Inc.
- UserBoondoggler22 Portfolio 1
- UserFATZ 1
- Userndecas Portfolio 1
- UserRooster Fund
- UserLGS-1 Portfolio 1
Latest FLML Headlines from TheStreet
- Flamel Technologies' CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.07.12 | 11:05 am
- Flamel Technologies' CEO Discusses Q4 2011 Results - Earnings Call Transcript 03.15.12 | 01:03 pm
- Flamel Technologies's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.03.11 | 11:11 am
- Flamel Technologies CEO Discusses Q2 2011 Results - Earnings Call Transcript 07.26.11 | 01:07 pm
- Flamel Technologies CEO Discusses Q1 2011 Results - Earnings Call Transcript 05.09.11 | 10:05 am
- Flamel Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript 03.04.11 | 12:03 pm
- Flamel Technologies CEO Discusses Q3 2010 Results - Earnings Call Transcript 11.05.10 | 11:11 pm
- Flamel Technologies SA Q2 2010 Earnings Call Transcript 07.29.10 | 02:07 pm
- Thursday's Health Winners & Losers 12.20.07 | 02:12 pm
- Wednesday's Health Winners & Losers 12.05.07 | 04:12 am
Press Releases for FLML
- Flamel Technologies Announces First Quarter 2012 Results - Business Wire 05.07.12 | 07:05 am
- Flamel Technologies Announces Fourth Quarter And Year-End 2011 Results - Business Wire 03.14.12 | 06:03 pm
- Flamel Technologies Announces Acquisition Of Éclat Pharmaceuticals - Business Wire 03.14.12 | 06:03 pm
- Flamel Technologies Announces Profitable Third Quarter Results - Business Wire 11.02.11 | 04:11 pm
- Flamel Technologies Announces Multi-Year Supply Agreement With GlaxoSmithKline For Coreg CR™ Microparticles - Business Wire 10.18.11 | 08:10 am
- Eagle Pharmaceuticals And Flamel Technologies Announce Eagle To License Medusa Technology For Extended-Release Of Tigecycline - Business Wire 10.13.11 | 09:10 am
- Flamel Technologies And Digna Biotech Announce Multiple Product Development Agreement - Business Wire 06.27.11 | 08:06 am
- Flamel Technologies Announces Results Of Annual Meeting - Business Wire 06.24.11 | 08:06 am
- Flamel Technologies Announces Nomination Of Ambassador Craig Stapleton, Dr. Catherine Bréchignac And Mr. Guillaume Cerutti For Election To The Board Of Directors - Business Wire 05.31.11 | 08:05 am
- Flamel Technologies Announces Expanded Partnership Relations; First Quarter Results - Business Wire 05.09.11 | 06:05 am
Partner Headlines for FLML
- 16 Micro-Cap Stocks Being Targeted By Short Sellers - Seeking Alpha 10.26.11 | 09:10 am
- Investors roll positions on options expiration day - Reuters 08.20.10 | 03:08 pm
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 08.04.10 | 09:08 am
